Astera Labs, Inc. $ALAB Shares Acquired by Numerai GP LLC

Numerai GP LLC increased its position in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 153.1% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 13,212 shares of the company’s stock after buying an additional 7,992 shares during the period. Numerai GP LLC’s holdings in Astera Labs were worth $2,587,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently added to or reduced their stakes in the company. Vanguard Group Inc. grew its stake in shares of Astera Labs by 14.1% during the third quarter. Vanguard Group Inc. now owns 13,743,141 shares of the company’s stock valued at $2,690,907,000 after acquiring an additional 1,693,918 shares in the last quarter. State Street Corp lifted its stake in shares of Astera Labs by 39.3% in the second quarter. State Street Corp now owns 2,143,459 shares of the company’s stock worth $193,812,000 after acquiring an additional 604,363 shares in the last quarter. 1832 Asset Management L.P. boosted its holdings in Astera Labs by 151.4% in the second quarter. 1832 Asset Management L.P. now owns 1,543,500 shares of the company’s stock valued at $139,563,000 after purchasing an additional 929,600 shares during the last quarter. Massachusetts Financial Services Co. MA boosted its holdings in Astera Labs by 46.6% in the third quarter. Massachusetts Financial Services Co. MA now owns 1,507,675 shares of the company’s stock valued at $295,203,000 after purchasing an additional 479,360 shares during the last quarter. Finally, Amundi grew its stake in Astera Labs by 1,298.6% during the 3rd quarter. Amundi now owns 1,421,263 shares of the company’s stock valued at $278,283,000 after purchasing an additional 1,319,643 shares in the last quarter. Institutional investors and hedge funds own 60.47% of the company’s stock.

Insider Buying and Selling at Astera Labs

In other Astera Labs news, COO Sanjay Gajendra sold 94,971 shares of the firm’s stock in a transaction on Tuesday, February 17th. The stock was sold at an average price of $123.81, for a total value of $11,758,359.51. Following the sale, the chief operating officer directly owned 1,531,301 shares in the company, valued at approximately $189,590,376.81. This trade represents a 5.84% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Jack R. Lazar sold 7,500 shares of the business’s stock in a transaction on Thursday, March 5th. The shares were sold at an average price of $119.80, for a total transaction of $898,500.00. Following the transaction, the director directly owned 87,351 shares of the company’s stock, valued at approximately $10,464,649.80. This trade represents a 7.91% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders have sold 224,292 shares of company stock worth $27,676,069. 12.50% of the stock is owned by company insiders.

Astera Labs Stock Up 6.0%

Shares of NASDAQ ALAB opened at $127.48 on Tuesday. The firm’s 50-day moving average price is $147.10 and its two-hundred day moving average price is $167.60. Astera Labs, Inc. has a 52-week low of $47.13 and a 52-week high of $262.90. The stock has a market capitalization of $21.70 billion, a P/E ratio of 104.49, a P/E/G ratio of 2.37 and a beta of 1.75.

Astera Labs (NASDAQ:ALAB) last posted its earnings results on Tuesday, February 10th. The company reported $0.58 EPS for the quarter, beating the consensus estimate of $0.51 by $0.07. The company had revenue of $270.58 million during the quarter, compared to analyst estimates of $249.46 million. Astera Labs had a return on equity of 16.12% and a net margin of 25.70%.The business’s revenue was up 91.8% compared to the same quarter last year. During the same period in the prior year, the company earned $0.37 earnings per share. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. As a group, equities research analysts expect that Astera Labs, Inc. will post 0.34 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on ALAB. Loop Capital assumed coverage on Astera Labs in a research report on Thursday, March 5th. They issued a “buy” rating and a $250.00 target price on the stock. BNP Paribas Exane started coverage on shares of Astera Labs in a research note on Thursday, November 20th. They issued an “outperform” rating for the company. Jefferies Financial Group reaffirmed a “buy” rating on shares of Astera Labs in a report on Wednesday, December 3rd. Citigroup decreased their price objective on shares of Astera Labs from $275.00 to $250.00 and set a “buy” rating for the company in a report on Wednesday, February 11th. Finally, Weiss Ratings downgraded shares of Astera Labs from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Monday, February 23rd. Fifteen research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, Astera Labs currently has an average rating of “Moderate Buy” and an average target price of $202.22.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.